share_log

ElectroCore's GammaCore Therapy Will Continue To Be Listed In The U.K's National Health Service Supply Chain Catalogue For Additional Two Years Till March 17, 2026. The Listing Commenced On June 4, 2019, Was Scheduled To Terminate On March 18, 2024

Benzinga ·  10/17/2023 20:03

ElectroCore's GammaCore Therapy Will Continue To Be Listed In The U.K's National Health Service Supply Chain Catalogue For Additional Two Years Till March 17, 2026. The Listing Commenced On June 4, 2019, Was Scheduled To Terminate On March 18, 2024

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment